Home › Cachexia
Cachexia clinical trials recruiting in the U.S.
8 studies for Cachexia are recruiting participants at sites across the United States.
Cities with the most studies
- Edison, NJ3 studies
- Nashville, TN3 studies
- Santa Monica, CA3 studies
- Portland, OR3 studies
- Omaha, NE3 studies
By state
- California3 studies
- Florida4 studies
- Georgia3 studies
- Kansas3 studies
- Nebraska3 studies
- New Jersey3 studies
- New York3 studies
- North Carolina3 studies
- Oregon3 studies
- Tennessee3 studies
- Texas3 studies
Recently updated studies
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06989437Visugromab in Cachexia International Trial
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07112196Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT05376592Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 16, 2026 · NCT05705492Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT06937177Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 100 · All sexes · Updated May 7, 2026 · NCT07083557Metabolism Evaluation Through Resting Indirect Calorimetry in Bladder Cancer (METRICS)
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 20, 2026 · NCT06721260A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jan 8, 2026 · NCT05865535From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.